Fermenta Biotech (BOM:506414) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:506414 Fermenta Biotech Ltd BOM:506414
65 GF Score
Price ₹499.30
GF Value ₹321.75
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Fermenta Biotech Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BOM:506414 vs ZTS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Fermenta Biotech's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fermenta Biotech Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fermenta Biotech's Short Interest distribution charts can be found below:

* The bar in red indicates where Fermenta Biotech's Short Interest falls into.


BOM:506414
65GF Score
Fermenta Biotech Ltd BOM:506414
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fermenta Biotech (BOM:506414) Overvalued in 2026?

Based on GuruFocus' analysis, Fermenta Biotech stock appears to be overvalued. The current stock price of ₹499.30 is trading 55.2% above its estimated GF Value™ of ₹321.75. GuruFocus considers Fermenta Biotech to be Significantly Overvalued.

Key valuation signals for BOM:506414:

  • Short Interest:
  • GF Value™: ₹321.75 vs. price of ₹499.30 (55.2% above fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the BOM:506414 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fermenta Biotech Business Description

Address Ghodbunder Road, A -1501, Thane One, DIL Complex, Majiwada, Thane (West), Thane, MH, IND, 400610
Fermenta Biotech Ltd is engaged in the business of manufacturing and marketing chemicals, bulk drugs, enzymes, pharmaceutical formulations, and environmental solution products and renting and selling properties. It is a manufacturer and supplier of Vitamin D and also supplies Penicillin G Amidase, CAL B Lipase, Polymer Supports, and enzyme technologies. The company operates in two segments namely Property and Bulk Drugs/Chemicals. The majority of the revenue comes from the Bulk Drug/Chemicals segment. Geographically, it caters to both domestic and international markets and generates maximum revenue from the Indian market.
65GF Score

Get the complete analysis for BOM:506414

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹499.30
Price
₹321.75
GF Value